| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/19/2004 | CN1150034C Drugs for relieving carbonyl stress and peritoneal dialysates |
| 05/19/2004 | CN1150031C Use of histamine of therapeutic purposes |
| 05/19/2004 | CN1150030C 重组人甲胎蛋白及其用途 And its use of recombinant human alpha-fetoprotein |
| 05/19/2004 | CN1150029C Methods for administration of antibiotics |
| 05/19/2004 | CN1150010C Method for removing farm chemical ingredients from ginseng extract |
| 05/19/2004 | CN1150007C Externally applied Chinese medicine for rheumatism and asthma |
| 05/19/2004 | CN1150003C Cell death inducers |
| 05/19/2004 | CN1150002C Antitumor compsn. contg. synergistic compsn. of anthracycline derivative with camptothecin derivate |
| 05/19/2004 | CN1150001C Injections contg. lipid A analogues and process for preparation thereof |
| 05/19/2004 | CN1150000C Compositions containing diphosphonic acids |
| 05/19/2004 | CN1149999C Pharmaceutical composition containing vitamin D and calcium, their preparation and therapeutic use |
| 05/19/2004 | CN1149998C New use of budesonide and formoterol |
| 05/19/2004 | CN1149997C Medicine composition |
| 05/19/2004 | CN1149996C Hexahydro-pyrido(4,3-B) indole derivatives as antipsychotic drugs |
| 05/19/2004 | CN1149995C Use of quinazolonone-containing compositions in pharmaceutical |
| 05/19/2004 | CN1149994C Oral compositions of levosimendan |
| 05/19/2004 | CN1149993C Pharmaceutical moxifloxacin preparation |
| 05/19/2004 | CN1149992C Antimycotic gel with active substance release |
| 05/19/2004 | CN1149991C Treatment of persistent pain |
| 05/19/2004 | CN1149990C Cyclooxygenase-2 inhibitor for treatment and prevention of tumors, tumor-related disorders and cachexia |
| 05/19/2004 | CN1149989C Application of skullcat stem and leaf general flavone and wild baicalin in preparing dementia resisting medicine |
| 05/19/2004 | CN1149988C Remed for hepatopathy |
| 05/19/2004 | CN1149987C Pharmaceutical composition comprising combination of dextro-and laevo-isomers of sotalol |
| 05/19/2004 | CN1149986C Use of medicine made by paracetamol for treating photophoby related to migraine |
| 05/19/2004 | CN1149985C Pharmaceutical compositions comprising S-(-)-N-Propargyl-1-amino indan |
| 05/19/2004 | CN1149984C Anesthetic compsn. for intravenous injection comprising propofol |
| 05/19/2004 | CN1149983C Compositions and methos for treatment of anorectal disorders |
| 05/19/2004 | CN1149982C Controlled releasing of steroid from sugarcoating |
| 05/19/2004 | CN1149981C Product with powder stable vitamine and/or carotenoid its producing process |
| 05/19/2004 | CN1149980C Spray-dried powders with high edible-oil loading based on non-bydrolyzed gelation and method of making such spry-dried tablettable powders |
| 05/19/2004 | CN1149979C Medicinal composition |
| 05/19/2004 | CN1149978C Quinolone-containing liposome composition and their preparation method |
| 05/19/2004 | CN1149977C Pharmaceutical compositions in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 05/19/2004 | CN1149971C Cosmetic or pharmaceutical compositions consisting of liposomes, its preparation method and use |
| 05/18/2004 | USRE38520 Erythromycin derivatives, method for preparing same, and use thereof as drugs |
| 05/18/2004 | US6737541 Preparation of nitrogen mustard derivatives |
| 05/18/2004 | US6737537 Platinum (II) antitumor compounds |
| 05/18/2004 | US6737535 Containing zeaxanthin fatty acid esters; stability; bioavail-ability |
| 05/18/2004 | US6737534 Using 10-deacetylbaccatine iii easily recovered in large amounts from taxus baccata leaves as starting material |
| 05/18/2004 | US6737522 Chicken interleukin-15 and uses thereof |
| 05/18/2004 | US6737518 Process for preparation of 4,5-epoxymorphinan-6-oxyglucuronides |
| 05/18/2004 | US6737507 Antiangiogenic peptides and compositions thereof |
| 05/18/2004 | US6737442 Food compositions for reducing insulin resistance |
| 05/18/2004 | US6737441 Preventing or treating persistent chronic gastritis, ulcers and/or stomach cancer |
| 05/18/2004 | US6737439 Active cancer chemopreventative and treating agents in mammals, including humans |
| 05/18/2004 | US6737437 EP4 receptor selective agonists in the treatment of osteoporosis |
| 05/18/2004 | US6737436 Pyrrole derivatives as phosphodiesterase VII inhibitors |
| 05/18/2004 | US6737435 Indole derivatives and their use as MCP-1 antagonist |
| 05/18/2004 | US6737434 Imidazole derivatives or their salts |
| 05/18/2004 | US6737431 Benzoxazole derivatives as novel melatonergic agents |
| 05/18/2004 | US6737430 Mutual prodrug of amlodipine and atorvastatin |
| 05/18/2004 | US6737429 Pyrrole derivatives |
| 05/18/2004 | US6737428 Respiratory syncytial virus |
| 05/18/2004 | US6737427 Administering to the patient suffering with the disease caused by overproduction of mucin such as chronic obstructive pulmonary diseases including asthma, emphysema, and chronic bronchitis a mucin glycoprotein synthesis inhibitor |
| 05/18/2004 | US6737426 Such as (4-phenylsulfonyl-2-pyridin-3-yl-oxazol-5-yl)-methylamine; anticonvulsants, antiinflammatories, neuro-protectants, cerebroprotectants, nootropics |
| 05/18/2004 | US6737425 N,N-substituted cyclic amine derivatives |
| 05/18/2004 | US6737424 Alpha-substituted pyridazino quinoline compounds |
| 05/18/2004 | US6737423 Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 05/18/2004 | US6737422 Voltage-dependent |
| 05/18/2004 | US6737421 4-carboxyamido substituted; neurodegenerative diseases; neuronal damage |
| 05/18/2004 | US6737420 Compounds to treat Alzheimer's disease |
| 05/18/2004 | US6737419 Stability |
| 05/18/2004 | US6737418 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 05/18/2004 | US6737415 Anti-bacterial agents based upon oxoanion binding |
| 05/18/2004 | US6737414 Composition for enteral nutrition comprising fibres |
| 05/18/2004 | US6737412 Antisense oligodeoxynucleotides regulating expression of TNF α |
| 05/18/2004 | US6737411 Racemization and enantiomer separation of clopidogrel |
| 05/18/2004 | US6737406 Cryptic peptides and method for their identification |
| 05/18/2004 | US6737400 Low dosage; side effect reduction |
| 05/18/2004 | US6737397 Control of cancer growth through the interaction of [MET5]-enkephalin and the zeta receptor |
| 05/18/2004 | US6737272 Methods for modulation of oocyte activation |
| 05/18/2004 | US6737271 Compound, composition and method for the treatment of inflammatory and inflammatory-related disorders |
| 05/18/2004 | US6737251 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 05/18/2004 | US6737246 Incubating substance with a mixture comprising a protein, marker substrate, which binds to the catalytic domain and is converted by the protein, and substrate; determining whether the marker substrate is converted by the protein |
| 05/18/2004 | US6737233 Method for preparing HCV E2 binding protein |
| 05/18/2004 | US6737232 IAPs associated cell cycle proteins, compositions and methods of use |
| 05/18/2004 | US6737086 For accelerating and amplifying the synthesis of thermal shock proteins of cells of living beings |
| 05/18/2004 | US6737085 Naturally derived antidepressant composition in the form of a food, dietary supplement, medicine or the like that contains neither hypericin nor hyperforin and is safer even during extended administration, for therapy of depression |
| 05/18/2004 | US6737084 Borage seed oil, angelica pubescens root, coleus forskohlii extract, vinpocetine, ferulic acid, magnesium, ascorbyl palmitate, capric/caprylic triglyceride, and silica; topical |
| 05/18/2004 | US6737082 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
| 05/18/2004 | US6737081 Melt congealing allotropic compound formulation into plurality of particles of uniform shape, exposing microspheres to atmosphere saturated with vapors of solvent for compound to effect solid state crystallization, recovering particles |
| 05/18/2004 | US6737080 Laminate comprising first moisture sensitive layer including moisture sensitive component, and second moisture absorbing layer including activated desiccant; spatial separation of layers prevents components from moving between layers |
| 05/18/2004 | US6737070 Topically applying to skin combination of peroxide and tertiary amine, with exclusion of erythromycin, which increases radicals formed by peroxide on/in skin to increase efficacy of peroxide in treatment of skin condition |
| 05/18/2004 | US6737068 Wipe formulation |
| 05/18/2004 | US6737044 Aerosol composition |
| 05/18/2004 | US6737043 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| 05/18/2004 | US6737042 Delivery of drug esters through an inhalation route |
| 05/18/2004 | US6737041 Non-ozone depleting vapocoolants |
| 05/18/2004 | CA2343719C New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 05/18/2004 | CA2334317C Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 05/18/2004 | CA2301794C Improved enriched platelet wound healant |
| 05/18/2004 | CA2301742C 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2 |
| 05/18/2004 | CA2298645C Use of physiologically acceptable vanadium compounds, salts and complexes |
| 05/18/2004 | CA2297279C New cyano-indole compounds that inhibit serotonin recapture, the process for their preparation and the pharmaceutical compounds that contain them |
| 05/18/2004 | CA2282427C Controlled release of pharmaceuticals in the anterior chamber of the eye |
| 05/18/2004 | CA2265881C Nodulisporic acid derivatives |
| 05/18/2004 | CA2248139C Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 05/18/2004 | CA2225746C 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
| 05/18/2004 | CA2214759C Intimal hypertrophy inhibitors |
| 05/18/2004 | CA2159485C Anti-oxydant alkylaryl polyether alcohol polymers |